New drug slows brain damage in MS patients in trial

A drug to treat multiple sclerosis has undergone successful trials showing its ability to slow damage to the brain, scientists have said.

Researchers testing ocrelizumab reported positive results in the treatment of primary progressive MS, a particularly aggressive form of the disease.